Наукові роботи студентів та аспірантів >
Студентське наукове товариство: статті, доповіді, тези >
Please use this identifier to cite or link to this item:
|Название: ||Verapamil usage in keloid and hypertrophic scar treatment|
|Авторы: ||Dongur, S. M.|
|Ключевые слова: ||тези доповідей|
|Issue Date: ||2019|
|Издатель: ||Запорізький державний медичний університет|
|Библиографическое описание: ||Dongur, S. M. Verapamil usage in keloid and hypertrophic scar treatment / S. M. Dongur // Актуальні питання сучасної медицини і фармації : зб. тез доп. наук.-практ. конф. з міжнарод. участю молодих вчених та студ., 13 – 17 травня 2019 р. - Запоріжжя, 2019. – С. 52|
|Аннотация: ||Introduction. Keloids and hypertrophic scars are the most common types of pathological scarring. Traditionally, keloids have been considered as a result of aberrant wound healing, involving excessive fibroblast participation that is characterized by hyalinized collagen bundles.However, the usefulness of this characterization has been questioned. In recent years, studies have reported the appropriate use of verapamil for keloids and hypertrophic scars.
Purpose of research. It is to know the effectiveness of the drug verapamil in comparison to other therapeutic drugs
Methods. Searches were conducted on the databases Medline, Embase, Cochrane, PubMed,and China National Knowledge Infrastructure. Treatment groups were divided intoverapamil and nonverapamil group. Nonverapamil group includes steroids and intense pulsedlight (IPL) therapy. Total effective rates include cure rate and effective rate. Cure: skin lesions were completely flattened, became soft and symptoms disappeared.
Results. Efficacy: skin lesions subsided, patient significantly reduced symptoms. Inefficient definition of skin was progression free or became worse. Random-effects model was used for the meta-analysis.Six studies that included 331 patients with keloids and hypertrophic scars were analyzed. Analysis of the total effective rate of skin healing was performed. The total effective rates in the two groups were 54.07% (verapamil) and 53.18% (nonverapamil), respectively. The meta-analysis showed that there was no difference between the two groups. The comparison is done between the adverse reactions of the verapamil treatment group and the steroids treatment group in two studies, and the result indicated that the verapamil group showed less adverse reactions.|
|Appears in Collections:||Студентське наукове товариство: статті, доповіді, тези|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.